NHI.no
Annonse
Informasjon

Urinlekkasje hos menn

Urininkontinens er uvanlig blant de yngste mennene, men fra 60-års alderen øker antallet tilfeller av inkontinens hos menn.

Dersom du har problemer med urinlekkasje, vil legen foreta en undersøkelse av endetarm og prostata.

Sist oppdatert:

15. apr. 2021

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Urininkontinens hos menn . Referanselisten for dette dokumentet vises nedenfor

  1. Abrams P, Chapple C, Khoury S, et al. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol 2013; 189: S93-S101.
  2. Schrӧder A. et al. European Association of Urology. Guidelines on urinary incontinence 2010.
  3. Bettez M, Tu le M, Carlson K, et al. 2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association. Can Urol Assoc J 2012; 6: 354-63. PubMed
  4. Abrams P, Cardozo L, Fall M, Griffiths D, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61: 37-49. PubMed
  5. Offermans MP, Du Moulin MF, Hamers JP, et al. Prevalence of urinary incontinence and associated risk factors in nursing home residents: a systematic review. Neurourol Urodyn 2009; 28: 288-94. PubMed
  6. Shamliyan TA, Wyman JF, Ping R, et al. Male urinary incontinence: prevalence, risk factors, and preventive interventions. Rev Urol 2009; 11: 145-65. PubMed
  7. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50: 1306-14. PubMed
  8. Catalona WJ, Carvalhal GF, Mager DE, Smith DS . Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433. pmid:10411052 PubMed
  9. Herschorn S, Bruschini H, Comiter C, et al. Surgical treatment of stress incontinence in men. Neurourol Urodyn 2010; 29: 179-90. PubMed
  10. JY,Kim HW, Lee SJ, et al. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 2004; 94: 817-20. PubMed
  11. Irwin DE, Milsom I, Reilly K, Hunskaar S, et al. Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men. J Sex Med 2008; 5: 2904-10. PubMed
  12. Kok ET, Schouten BW, Bohnen AM, et al. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. J Urol 2009; 181: 710-16. PubMed
  13. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 2007; 178: 395-401. PubMed
  14. Tennstedt SL, Chiu GR, Link CL, et al. The effects of severity of urine leakage on quality of life in Hispanic, white, and black men and women: the Boston community health survey. Urology 2010; 75: 27. pmid:19854479 PubMed
  15. Fujimura T, Kume H, Nishimatsu H, et al. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score. BJU Int 2012; 109: 1512-6. PubMed
  16. McNaughton-Collins M, Barry MJ. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Am J Med 2005; 118: 1331-9. PubMed
  17. Lee SW, Doo SW, Yang WJ, Song YS. Importance of relieving the most bothersome symptom for improving quality of life in male patients with lower urinary tract symptoms. Urology 2012; 80: 684-7. PubMed
  18. Cui Y, Zong H, Yang C, et al. The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials. Int Urol Nephrol. 2014 ;46(1):275-84. doi: 10.1007/s11255-013-0509-9. DOI
  19. Yeowell G, Smith P, Nazir J, et al. Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review. BMJ Open. 2018. PMID: 30467131 PubMed
  20. Kelleher C, Hakimi Z, Zur R et al. Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis. Eur Urol. 2018 Sep;74(3):324-333. Epub 2018 Apr 23. PMID: 29699858. PubMed
  21. Rai BP, Cody JD, Alhasso A, Stewart L. Anticholinergic drugs versus non‐drug active therapies for non‐neurogenic overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD003193. DOI: 10.1002/14651858.CD003193.pub4. Accessed 13 April 2021 The Cochrane Library
  22. Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD005493. DOI: 10.1002/14651858.CD005493.pub3. Accessed 13 April 2021. The Cochrane Library
  23. Tsakiris P, de la Rosette JJ, Michel MC, Oelke M. Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur Urol 2008; 53: 53-9. PubMed
  24. Bekelman JE, Rumble RB, Chen RC, et al. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline. J Clin Oncol 2018; 36: 3251. pmid: 30183466 PubMed
  25. Anderson CA, Omar MI, Campbell SE, et al. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev. 2015 Jan 20;1:CD001843. Cochrane (DOI)
  26. Bauer RM, Gozzi C, Hübner W, et al. Contemporary management of postprostatectomy incontinence. Eur Urol 2011; 59: 985-96. PubMed
  27. Welk BK, Herschorn S. The male sling for post-prostatectomy urinary incontinence: a review of contemporary sling designs and outcomes. BJU In 2012; 109: 328-44. PubMed
  28. Bauer RM, Bastian PJ, Gozzi C, Stief CG. Postprostatectomy incontinence: all about diagnosis and management. Eur Urol 2009; 55: 322-33. PubMed
  29. Suarez OA, McCammon KA. The Artificial Urinary Sphincter in the Management of Incontinence. Urology 2016; 92: 14. pmid:26845050 PubMed
  30. Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010; 29: 213-40. PubMed
  31. Murray S, Lemack GE. Overactive bladder and mixed incontinence. Curr Urol Rep 2010; 11: 385-92. PubMed
  32. Sacco E, Bientinesi R, Marangi F, et al. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study. BJU Int 2012; 110: E837-44. PubMed
  33. Trost L, Elliott DS. Male stress urinary incontinence: a review of surgical treatment options and outcomes. Adv Urol 2012; 2012: 1-13. PubMed
  34. Eden CG, Arora A, Hutton A. Cancer control, continence, and potency after laparoscopic radical prostatectomy beyond the learning and discovery curves. J Endourol 2011; 25: 815-9. PubMed
  35. Treiyer A, Anheuser P, Bütow Z, Steffens J. A single center prospective study: prediction of postoperative general quality of life, potency and continence after radical retropubic prostatectomy. J Urol 2011; 185: 1681-5. PubMed
Annonse
Annonse